Reliability and Validity of the LifeWindows Information–Motivation–Behavioral Skills Antiretroviral Therapy Adherence Questionnaire Among HIV+ Patients in Shanghai

References

• Huang MB, Ye L, Liang BY, et al. Characterizing the HIV/AIDS epidemic in the United States and China. Int J Environ Res Public Health. 2015;13(1):30. doi:10.3390/ijerph13010030
   Web of Science ®Google Scholar
• Yang S, Wu J, Ding C, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17(7):716–725. doi:10.1016/S1473-3099(17)30227-X
   PubMed Web of Science ®Google Scholar
• Unaids Joint United Nations Programme on Hiv/aids. 90-90-90 An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva Switzerland: UnaidsJoint United Nations Programme on Hiv/aids; 2014.
   Google Scholar
• Lucas GM. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother. 2005;55(4):413–416. doi:10.1093/jac/dki042
   PubMed Web of Science ®Google Scholar
• Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697–706. doi:10.1056/NEJMoa0905848
   PubMed Web of Science ®Google Scholar
• Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. doi:10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368(9534):531–536. doi:10.1016/S0140-6736(06)69162-9
   PubMed Web of Science ®Google Scholar
• Wood E, Milloy MJ, Montaner JS. HIV treatment as prevention among injection drug users. Curr Opin HIV AIDS. 2012;7(2):151–156. doi:10.1097/COH.0b013e32834f9927
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi:10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Mastro TD. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2003;17(Suppl 4):S123–124. (). doi:10.1097/00002030-200317004-00025
   Google Scholar
• Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–1183. doi:10.1097/00002030-200106150-00015
   PubMed Web of Science ®Google Scholar
• Byrd KK, Hou JG, Hazen R, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82:245–251. doi:10.1097/QAI.0000000000002142
   PubMed Web of Science ®Google Scholar
• Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S2–S10. doi:10.1097/00126334-200202011-00002
   PubMed Web of Science ®Google Scholar
• Ortego C, Huedo-medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–1396. doi:10.1007/s10461-011-9942-x
   PubMed Web of Science ®Google Scholar
• Kelly JD, Giordano TP. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(8):1137. (). doi:10.1097/QAD.0b013e32834670d7
   PubMed Web of Science ®Google Scholar
• Abara WE, Adekeye OA, Xu J, Heiman HJ, Rust G. Correlates of combination antiretroviral adherence among recently diagnosed older HIV-infected adults between 50 and 64 years. AIDS Behav. 2016;20(11):2674–2681. doi:10.1007/s10461-016-1325-x
   PubMed Web of Science ®Google Scholar
• Beer L, Skarbinski J. Adherence to antiretroviral therapy among HIV-infected adults in the United States. AIDS Educ Prev. 2014;26(6):521–537. doi:10.1521/aeap.2014.26.6.521
   PubMed Web of Science ®Google Scholar
• Amico KR, Barta W, Konkle-parker DJ, et al. The information-motivation-behavioral skills model of ART adherence in a deep south HIV+ clinic sample. AIDS Behav. 2009;13(1):66–75. doi:10.1007/s10461-007-9311-y
   PubMed Web of Science ®Google Scholar
• Norton WE, Amico KR, Fisher WA, et al. Information-motivation-behavioral skills barriers associated with intentional versus unintentional ARV non-adherence behavior among HIV+ patients in clinical care. AIDS Care. 2010;22(8):979–987. doi:10.1080/09540121003758630
   PubMed Web of Science ®Google Scholar
• Santillan Torres Torija C, Villagran Vazquez G, Robles Montijo SS, de Lourdes Eguiluz Romo L. The information and motivation and behavioral skills model of ART adherence among HIV-positive adults in Mexico. J Int Assoc Provid AIDS Care. 2015;14(4):335–342. doi:10.1177/2325957415581903
   PubMedGoogle Scholar
• Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–473. doi:10.1037/0278-6133.25.4.462
   PubMed Web of Science ®Google Scholar
• Bertholon DR, Rossert H, Korsia S. The patient’s perspective on life with antiretroviral treatment: results of an 887-person survey. AIDS Read. 1999;9(7):462–469.
   PubMedGoogle Scholar
• Horvath KJ, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care. 2014;26(2):142–151. doi:10.1080/09540121.2013.802283
   PubMed Web of Science ®Google Scholar
• Rongkavilit C, Naar-king S, Kaljee LM, et al. Applying the information-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: a qualitative study. AIDS Patient Care STDS. 2010;24(12):787–794. doi:10.1089/apc.2010.0069
   PubMed Web of Science ®Google Scholar
• Gordon CM. Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions. Research Directions and Implications for Practice. J Acquir Immune Def Syndr 2006;43(Suppl 1):S36–S40. doi:10.1097/01.qai.0000248347.87512.ba
   PubMed Web of Science ®Google Scholar
• Dilorio CK. Measurement in Health Behavior: Methods for Research and Education. Sanfrancisco: Jossey Bass; 2005.
   Google Scholar
• Kwon M, Kim DJ, Cho H, Yang S. The smartphone addiction scale: development and validation of a short version for adolescents. PLoS One. 2013;8(12):e83558. doi:10.1371/journal.pone.0083558
   PubMed Web of Science ®Google Scholar
• Berglund AL, Ericsson K. Different meanings of quality of life: a comparison between what elderly persons and geriatric staff believe is of importance. Int J Nurs Pract. 2003;9(2):112–119. doi:10.1046/j.1322-7114.2003.00414.x
   Google Scholar
• Samuel DB, South SC, Griffin SA. Factorial invariance of the five-factor model rating form across gender. Assessment. 2015;22(1):65–75. doi:10.1177/1073191114536772
   PubMed Web of Science ®Google Scholar
• McDonald RP, Ho MH. Principles and practice in reporting structural equation analyses. Psychol Methods. 2002;7(1):64–82. doi:10.1037/1082-989X.7.1.64
   PubMed Web of Science ®Google Scholar
• Chen TF, Chou KR, Liao YM, Ho CH, Chung MH. Construct validity and reliability of the Chinese version of the disaster preparedness evaluation tool in Taiwan. J Clin Nurs. 2015;24(7–8):1132–1143. doi:10.1111/jocn.12721
   Web of Science ®Google Scholar
• Siril H, Fawzi MC, Todd J, et al. Hopefulness fosters affective and cognitive constructs for actions to cope and enhance quality of life among people living with HIV in Dar Es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2017;16(2):140–148. doi:10.1177/2325957414539195
   PubMedGoogle Scholar
• Dalmida SG, McCoy K, Koenig HG, et al. Examination of the role of religious and psychosocial factors in HIV medication adherence rates. J Relig Health. 2017;56(6):2144–2161. doi:10.1007/s10943-017-0377-1
   PubMed Web of Science ®Google Scholar
• Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123–S127. doi:10.1097/00126334-200212153-00007
   PubMed Web of Science ®Google Scholar
• Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008;5:13. doi:10.1186/1742-4690-5-13
   PubMed Web of Science ®Google Scholar
• Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44(9):1175–1184. doi:10.1037/0003-066X.44.9.1175
   PubMed Web of Science ®Google Scholar
• Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV treatment adherence self-efficacy scale (HIV-ASES). J Behav Med. 2007;30(5):359–370. doi:10.1007/s10865-007-9118-3
   PubMed Web of Science ®Google Scholar
• Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124–133. doi:10.1037/0278-6133.19.2.124
   PubMed Web of Science ®Google Scholar